Clinical Trial Update: Intralipid Therapy for Recurrent Implantation Failure and Recurrent Miscarriages: Is it a Hope or Myth?A Randomized Clinical Trial [Phase 4]

View source ↗

Summary

A Phase 4 randomized trial of Intralipid therapy for pregnancy complications related to low implantation has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pregnancy Complications with Low Implantation

Drugs mentioned

• Intralipid therapy (Intralipid)

Snippet

Sponsor: Woman's Health University Hospital, Egypt | Conditions: Pregnancy Complicated by Low Implantation | Phase 4 | Status: WITHDRAWN